£595.00

The 2016-2021 Outlook for Prostate Cancer Therapeutics in Japan

Price data last checked 95 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£595 today · cheaper than every other day in the last 23 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 605 days • 605 data points (No recent data available)

Historical
Generating forecast...
£595.00 £565.25 £577.15 £589.05 £600.95 £612.85 £624.75 12 July 2024 10 December 2024 10 May 2025 08 October 2025 08 March 2026

Price Distribution

Price distribution over 605 days • 1 price levels

Days at Price
605 days 0 151 303 454 605 £595 Days at Price

Price Analysis

Most common price: £595 (605 days, 100.0%)

Price range: £595 - £595

Price levels: 1 different prices over 605 days

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
22 September 2015
Listed Since
14 December 2016

Similar Products You Might Like

The 2013-2018 Outlook for Prostate Cancer Therapeutics in Africa
98% match

The 2013-2018 Outlook for Prostate Cancer Therapeutics in Africa

£325.00 06 Feb 2026
The 2025-2030 World Outlook for Prostate Cancer Treatments
98% match

The 2025-2030 World Outlook for Prostate Cancer Treatments

Out of Stock 07 Feb 2026
The 2023-2028 Outlook for Hormone Therapy for Prostate Cancer Therapeutics in the United States
98% match

The 2023-2028 Outlook for Hormone Therapy for Prostate Cancer Therapeutics in the United States

£520.00 14 Jan 2026
The 2023-2028 Outlook for Hormone Therapy for Prostate Cancer Therapeutics in India
98% match

The 2023-2028 Outlook for Hormone Therapy for Prostate Cancer Therapeutics in India

£515.00 12 Jan 2026
The 2023-2028 Outlook for Prostate Cancer Nuclear Medicine Diagnostics in India
98% match

The 2023-2028 Outlook for Prostate Cancer Nuclear Medicine Diagnostics in India

£515.00 07 Jan 2026
The 2025-2030 World Outlook for Prostate Cancer Treatments and Prevention
98% match

The 2025-2030 World Outlook for Prostate Cancer Treatments and Prevention

Out of Stock 11 Feb 2026
The 2023-2028 Outlook for Hormone Therapy for Prostate Cancer Therapeutics in Japan
98% match

The 2023-2028 Outlook for Hormone Therapy for Prostate Cancer Therapeutics in Japan

£495.00 13 Jan 2026
The 2023-2028 Outlook for Hormone Therapy for Prostate Cancer Therapeutics in China
97% match

The 2023-2028 Outlook for Hormone Therapy for Prostate Cancer Therapeutics in China

£495.00 09 Jan 2026
The 2016-2021 Outlook for Bladder Cancer Therapeutics in Japan
97% match

The 2016-2021 Outlook for Bladder Cancer Therapeutics in Japan

£595.00 01 Feb 2026
The 2016-2021 World Outlook for Non-Small Cell Lung Cancer Therapeutics
97% match

The 2016-2021 World Outlook for Non-Small Cell Lung Cancer Therapeutics

£995.00 11 Jan 2026
The 2023-2028 Outlook for Cancer Supportive Care in the United States
97% match

The 2023-2028 Outlook for Cancer Supportive Care in the United States

£520.00 24 Jan 2026
The 2023-2028 Outlook for Prostate Cancer Nuclear Medicine Diagnostics in China
97% match

The 2023-2028 Outlook for Prostate Cancer Nuclear Medicine Diagnostics in China

£495.00 14 Jan 2026
The 2021-2026 World Outlook for Silent Cancer Therapeutics
97% match

The 2021-2026 World Outlook for Silent Cancer Therapeutics

£795.00 08 Jan 2026
The 2025-2030 World Outlook for Hormone Therapy for Prostate Cancer Therapeutics
97% match

The 2025-2030 World Outlook for Hormone Therapy for Prostate Cancer Therapeutics

Out of Stock 13 Feb 2026
The 2016-2021 Outlook for Pancreatic Cancer Drugs in the United States
97% match

The 2016-2021 Outlook for Pancreatic Cancer Drugs in the United States

£595.00 25 Jan 2026
The 2023-2028 Outlook for Cancer Supportive Care Drugs in India
97% match

The 2023-2028 Outlook for Cancer Supportive Care Drugs in India

£515.00 22 Jan 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in India
97% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in India

£515.00 09 Apr 2026
The 2016-2021 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States
97% match

The 2016-2021 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States

£595.00 12 Jan 2026
The 2023-2028 Outlook for Cancer Supportive Care Drugs in the United States
97% match

The 2023-2028 Outlook for Cancer Supportive Care Drugs in the United States

£520.00 22 Jan 2026
The 2023-2028 Outlook for Cancer Screenings in the United States
97% match

The 2023-2028 Outlook for Cancer Screenings in the United States

£520.00 15 Jan 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States
97% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States

£520.00 10 Apr 2026
The 2023-2028 Outlook for Prostate Cancer Nuclear Medicine Diagnostics for US Zip Codes
97% match

The 2023-2028 Outlook for Prostate Cancer Nuclear Medicine Diagnostics for US Zip Codes

£490.00 25 Jan 2026
Current Status of Prostate Cancer: Diagnosis, Biomarkers and Therapies (Volume 161) (Advances in Cancer Research, Volume 161)
97% match

Current Status of Prostate Cancer: Diagnosis, Biomarkers and Therapies (Volume 161) (Advances in Cancer Research, Volume 161)

Academic Press

£113.98 07 Mar 2026
The 2016-2021 Outlook for Cancer Therapies in Asia
96% match

The 2016-2021 Outlook for Cancer Therapies in Asia

£425.00 24 Jan 2026